18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR1900026244
尚未开始
/
/
/
2019-09-28
/
/
乳腺癌
乳腺癌生存者自我管理應用程式的隨機對照試驗
Breast Cancer App protocol: a randomized controlled trial to evaluate a self-management app for breast cancer survivors
1) to examine whether there is the difference in the health literacy, problem solving skills, readiness of change, self-efficacy, self-management skill, and health-related quality of life between the intervention group and the control group; 2) to examine the usability of this self-management app versus a general health app.
随机平行对照
探索性研究/预试验
SPSS (IBM SPSS Statistics Version 25) will be used to generate the random sequence for group allocation.
Not addressed
Departmental research fund
/
244
/
2020-01-01
2021-06-30
/
1) female; 2) breast cancer survivors; 3) Cancer stages I to III; 4) completion of primary treatment within one year or longer; 5) aged 18 to 65 years; 6) acceptable literacy level (e.g. able to read, and write Chinese); 7) agree for checking of usage log of mobile app; 8) able to provide informed consent.;
登录查看1) BCS diagnosed with severe mental illnesses; 2) Diagnosis of another cancer type rather than breast cancer; 3) has already participated in other clinical trial; 4) has been used other self-management app to manage the breast cancer.;
登录查看香港理工大學康復科學系
/
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22